01:18 , Jun 21, 2006 |  BC Extra  |  Financial News

Rib-X raises $50 million

Rib-X (New Haven, Conn.) raised $50 million in a series C round led by Warburg Pincus . MedImmune Ventures and Radius joined existing investors ABS Ventures; Axiom Venture Partners; Cardinal Partners; EuclidSR; Oxford Bioscience Partners;...
08:00 , Mar 29, 2004 |  BioCentury  |  Strategy

All that Jazz . . .

All that Jazz . . . Company Raised Date Focus Investors Jazz $250.0 3/24/04 Neurology, cancer, endocrine Kohlberg Kravis Roberts; Prospect Venture Partners; Versant Ventures; Beecken Petty O'Keefe; Golden Gate Capital; Thoma Cressey Equity Partners;...
08:00 , Mar 15, 2004 |  BioCentury  |  Finance

'A' for effort

'A' for effort Company Raised Date Focus Country Investors Pedigree Biovitrum $85.0 8/1/01 Metabolic Sweden MPM Capital; Nordic Capital; Karolinska Investment Fund; ABN AMRO; Carnegie Asset Management; H&B Capital; Next Gear Spun out of Pharmacia...
08:00 , Mar 9, 2004 |  BC Extra  |  Financial News

Aspreva raises $53 million

Aspreva raised $53 million in a series A round led by Sprout Group. Other investors included InterWest; HBM Partners; Thomas Weisel Healthcare Ventures; BioAsia Investments; and Axiom Venture Partners. Aspreva (Victoria, B.C.) issued an additional...
07:00 , May 26, 2003 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Sagres Discovery Inc. Davis, Calif. Technology: High throughput insertional mutagenesis Disease focus: Cancer Clinical status: Discovery Founded: 2000 by David Morris; Michael Miille; Marc Malandro; David Ferrick; Matthias Wabl Corporate partners: Boehringer Ingelheim GmbH University...
07:00 , May 5, 2003 |  BioCentury  |  Finance

Ebb & Flow

CEOs trying to transition from "platform" to "product" may learn some lessons from the failure of Signature BioScience, which closed its doors last week. Signature was attempting to reinvent itself into a drug development company,...
07:00 , May 1, 2003 |  BC Extra  |  Top Story

Rib-X raises $51 million

Infectious disease company Rib-X raised $51 million in a series B round led by Warburg Pincus , which put in $31 million. The company is in preclinical development of small molecule antibiotics based on the...
07:00 , Apr 29, 2002 |  BioCentury  |  Finance

Ebb & Flow

It was an especially dour week for biotech in spite of decent earnings news. The BioCentury 100 index slipped almost 11% on the week to 1323, despite seven out of eight profitable product companies meeting...
07:00 , Apr 25, 2002 |  BC Extra  |  Financial News

Dynavax raises $34.8 million

Dynavax (Berkeley, Calif.) raised $34.8 million in a series D round led by Care Capital. Other investors included Piper Jaffray Ventures; BioVeda; HealthCap; Lotus BioScience Holdings; Forward Ventures; Sanderling; BA Ventures; WestLB Asset Management; JAFCO;...
07:00 , Oct 8, 2001 |  BioCentury  |  Finance

Ebb & Flow

Whether it's a dead-cat bounce or the start of a rally, biotech has posted the best performance of the major indexes tracked by BioCentury over the past two weeks. Since Sept. 21 - the Friday...